Subject(s)
COVID-19 , Communication Barriers , Healthcare Disparities/ethnology , Limited English Proficiency , Minority Health , COVID-19/epidemiology , COVID-19/psychology , COVID-19/therapy , Culturally Competent Care/organization & administration , Ethnic and Racial Minorities , Humans , SARS-CoV-2 , Translating , United States/epidemiologyABSTRACT
Vulnerable refugee communities are disproportionately affected by the ongoing COVID-19 pandemic; existing longstanding health inequity in these communities is exacerbated by ineffective risk communication practices about COVID-19. Culturally and linguistically appropriate health communication following health literacy guidelines is needed to dispel cultural myths, social stigma, misinformation, and disinformation. For refugee communities, the physical, mental, and social-related consequences of displacement further complicate understanding of risk communication practices grounded in a Western cultural ethos. We present a case study of Clarkston, Georgia, the "most diverse square mile in America," where half the population is foreign born and majority refugee. Supporting marginalized communities in times of risk will require a multipronged, systemic approach to health communication including: (1) creating a task force of local leaders and community members to deal with emergent issues; (2) expanding English-language education and support for refugees; (3) including refugee perspectives on risk, health, and wellness into risk communication messaging; (4) improving cultural competence and health literacy training for community leaders and healthcare providers; and (5) supporting community health workers. Finally, better prepared public health programs, including partnerships with trusted community organizations and leadership, can ensure that appropriate and supportive risk communication and health education and promotion are in place long before the next emergency.
Subject(s)
COVID-19/therapy , Community Health Workers/organization & administration , Culturally Competent Care/organization & administration , Health Promotion/organization & administration , Health Status Indicators , Refugees/statistics & numerical data , COVID-19/epidemiology , Georgia , Humans , Needs Assessment/organization & administrationSubject(s)
COVID-19 , Culturally Competent Care , Hispanic or Latino , Mental Disorders , Telemedicine , COVID-19/epidemiology , COVID-19/psychology , Culturally Competent Care/methods , Culturally Competent Care/organization & administration , Health Education/methods , Health Services Needs and Demand , Healthcare Disparities , Hispanic or Latino/psychology , Hispanic or Latino/statistics & numerical data , Humans , Mental Disorders/ethnology , Mental Disorders/psychology , Mental Disorders/therapy , Mental Health/ethnology , Patient Participation/methods , SARS-CoV-2 , Telemedicine/methods , Telemedicine/organization & administration , United StatesSubject(s)
Culturally Competent Care/organization & administration , Health Status Disparities , Healthcare Disparities/ethnology , Minority Groups/statistics & numerical data , COVID-19/epidemiology , COVID-19/ethnology , COVID-19/prevention & control , COVID-19 Vaccines/administration & dosage , Clinical Trials as Topic/statistics & numerical data , Community Participation/statistics & numerical data , Culturally Competent Care/statistics & numerical data , Ethnicity/statistics & numerical data , Health Services Research/organization & administration , Health Services Research/statistics & numerical data , Humans , Patient Selection , Racial Groups/statistics & numerical data , United Kingdom/epidemiologySubject(s)
COVID-19 Vaccines/therapeutic use , COVID-19 , Ethnicity , Health Knowledge, Attitudes, Practice , Patient Acceptance of Health Care , Vaccination Refusal , COVID-19/epidemiology , COVID-19/prevention & control , Culturally Competent Care/organization & administration , Culturally Competent Care/standards , Ethnicity/classification , Ethnicity/statistics & numerical data , Humans , Minority Health , Patient Acceptance of Health Care/ethnology , Patient Acceptance of Health Care/statistics & numerical data , Public Health/methods , Public Health/standards , Quality Improvement , SARS-CoV-2 , United Kingdom/epidemiology , Vaccination Refusal/ethics , Vaccination Refusal/ethnology , Vaccination Refusal/psychologyABSTRACT
If we were told that one day the entire world would take its guidance for managing a health crisis from empirical thought, nobody would have believed it. However, with the December 2019 arrival of COVID-19 in China, the world subsequently went into a frenzied state that resulted in the widespread adoption of untested strategies or potential cures; circumstantial evidence provided without randomized control trials (RCTs) was published rapidly and widely considered the gold standard in medical research and therapeutics. Nigeria and much of the rest of the world blindly adopted treatments like chloroquine or hydroxychloroquine and various prevention strategies, often without monitoring the efficacy of these treatment and social control strategies. COVID-19 provided Nigeria a critical opportunity to create or strengthen its national laboratory system by building up its Level 3 laboratories in all parts of the country with the capability to perform PCR tests and viral isolation. There was also an opportunity to establish hospitals in every region of a sufficient standard to reduce the numbers of Nigerians travelling abroad to seek medical treatment; to invest in building capacity to develop antiviral medications and vaccines in Nigeria, and to ensure better international health policies. Rather, Nigerian leaders, government and health managers decided (like most other nations of the world) to shut down the society using isolationist policies that were not necessarily tailored to local needs. Despite adopting these methods, COVID-19 cases continued to skyrocket in Nigeria. In the future, before adopting such broad sweeping policies, there should be local tailoring to assess their effectiveness in different communities. Given that the country has much experience in controlling Lassa and Marburg Fever outbreaks, Nigeria should lead by developing new strategies, new protocols and new local guidelines, based on validated and reproducible studies to ensure that the public health authorities are not caught unaware by any new outbreaks of emerging or remerging diseases.